Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan
NCT07027332 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2025-06-18
Summary
Polycystic Ovary Syndrome (PCOS) is a complex endocrine and metabolic disorder prevalent among women of reproductive age. It is closely associated with insulin resistance, obesity, and metabolic dysfunction, often leading to hepatic steatosis (fatty liver). This single-center, cross-sectional, case-control study evaluates liver function in PCOS patients using FibroScan, a non-invasive elastography technique. Eighteen women diagnosed with PCOS according to Rotterdam criteria and 18 age- and BMI-matched healthy controls aged 18-45 years were included. The study aims to determine whether PCOS independently affects hepatic steatosis and to assess the clinical applicability of FibroScan in this population. The results may inform early metabolic risk detection and improve multidisciplinary management strategies for PCOS.
Conditions
- Polycystic Ovary Syndrome
- Non-Alcoholic Fatty Liver Disease
Interventions
- DIAGNOSTIC_TEST
-
FibroScan® (Echosens, Paris, France)
A non-invasive liver elastography device used for clinical assessment. Liver steatosis and stiffness are measured in participants using the FibroScan device.
Sponsors & Collaborators
-
Bezmialem Vakif University
lead OTHER
Principal Investigators
-
Zeynep Gayhan, Medicine · Bezmialem Vakif University
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-29
- Primary Completion
- 2025-01-30
- Completion
- 2025-03-08
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Evaluation of Serum Scube-1 Scube-2 and Scube-3 Levels in Patients With Polikistik Over Syndrome ,
NCT03765905 ·Status: COMPLETED
-
Post-Prandial Liver Glucose Metabolism in PCOS
NCT03041129 ·Status: COMPLETED
-
Activity of Chronic Inflammation in PCOS
NCT06300593 ·Status: COMPLETED
-
Short Term Ketogenic Diet in Polycictic Ovary Syndrome
NCT06469255 ·Status: COMPLETED ·Phase: NA
-
Phenotyping of Patients With Polycystic Ovary Syndrome
NCT07339930 ·Status: RECRUITING
-
Prevalence of HbA1C in Women With PCOS
NCT01838122 ·Status: UNKNOWN
-
Correlation of Insulin Resistance With Hormonal and Ovarian Morphological Characteristics in Patients With Polycystic Ovarian Syndrome
NCT05661565 ·Status: UNKNOWN
-
THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOS
NCT01735799 ·Status: UNKNOWN
-
IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome
NCT05756023 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial
NCT07278128 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adipose Tissue Gene Expression Profiles in Women With Polycystic Ovary Syndrome (PCOS) Versus Controls
NCT01195142 ·Status: COMPLETED
-
Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity
NCT01382576 ·Status: COMPLETED
-
Association of Vitamin D Status With Metabolic Markers in Adolescents With Polycystic Ovary Syndrome
NCT06970821 ·Status: COMPLETED
-
Epicardial Adipose Tissue Thickness in Polycystic Ovary Syndrome (PCOS)
NCT01258946 ·Status: COMPLETED
-
Serum Endocan Levels in Polycystic Ovary Syndrome
NCT03019679 ·Status: COMPLETED
-
Pro- and Anti-inflammatory Cytokines in PCOS
NCT06793085 ·Status: RECRUITING
-
Adipokines in Polycystic Ovary Syndrome
NCT06793072 ·Status: RECRUITING
-
Ovarian Innervation Study in Patients With Polycystic Ovary Syndrome (PCOS)
NCT05966571 ·Status: UNKNOWN
-
Protein and Polycystic Ovary Syndrome (PCOS)
NCT07158723 ·Status: RECRUITING ·Phase: NA
-
Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study
NCT07094776 ·Status: ENROLLING_BY_INVITATION
-
Comparison of Bone Morphogenetic Protein-4 (BMP-4) and 7 Levels Between Control and Polycystic Ovarian Syndrome (PCOS) Patients.
NCT01162447 ·Status: UNKNOWN
-
Comparison of Docosahexaenoic (DHA) Values in Patients With Polycystic Ovary Syndrome (PCOS)
NCT05597111 ·Status: UNKNOWN
-
Adipocytokines and Polycystic Ovary Syndrome (PCOS)
NCT00975832 ·Status: COMPLETED
-
Nutrition Intervention for Women With Polycystic Ovary Syndrome
NCT07298603 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Eye Evaluation in Patients With PCOS
NCT01950832 ·Status: COMPLETED